← Back to All Filings

Procter & Gamble Health Care CEO Sells $698K in Stock

Medium SignificanceOctober 26, 2026 at 10:08:49 AM EDT

PROCTER & GAMBLE Co

$PG4CIK: 0000080424

Subscribe to track PG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Insider Sale Alert: Procter & Gamble Co ($PG)
**Insider**: Paul Gama (CEO- Health Care)
**Transaction**: Sold 4,331 shares at $161.27 per share
**Total Value**: $698,460.37
**Date**: October 23, 2026
**Shares Held After**: 46,792.88 direct (plus 1,183.97 indirect)
**10b5-1 Plan**: No

Comprehensive Analysis

Insider Transaction Overview

On October 23, 2026, Paul Gama, CEO of Health Care at Procter & Gamble Co ($PG), disposed of 4,331 shares of Common Stock in an open market sale (Code: S). The shares were sold at a price of $161.27 each, yielding gross transaction proceeds of $698,460.37.

Holdings Analysis

  • Pre-Transaction Direct Holdings: Approximately 51,123.88 shares.
  • Shares Sold: 4,331 shares (~8.5% of direct holdings).
  • Post-Transaction Direct Holdings: 46,792.88 shares.
  • Indirect Holdings: 1,183.97 shares held via Retirement Plan Trustee.
  • Rule 10b5-1 Indicator: The filing indicates that this transaction was not executed pursuant to a pre-established Rule 10b5-1 trading plan.

Significance & Market Context

While open market insider sales by senior corporate officers warrant observation, Paul Gama retains a significant equity stake totaling over 47,900 shares across direct and indirect accounts. The sale represents a modest reduction in his direct position and was not part of an automated 10b5-1 plan, leading to a Medium trading significance rating.

Topics:#PG#ProcterAndGamble#InsiderTrading#StockMarket#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.